Drug Topics

NOVEMBER 14, 2024

Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.

187

187

Pharmacy Times

NOVEMBER 14, 2024

Eladocagene exuparvovec-tneq is the first FDA-approved gene therapy for with aromatic L-amino acid decarboxylase deficiency.

FDA 144

FDA 144

Fierce Pharma

NOVEMBER 14, 2024

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy has already been approved to treat AADC deficiency in Europe and the U.K., among other countries, where it's branded as Upstaza.

FDA 143

FDA 143

Fierce Healthcare

NOVEMBER 14, 2024

Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.

143

143

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

NOVEMBER 14, 2024

The 2024 American Heart Association and American Stroke Association stroke prevention guidelines recommend glucagon-like peptide-1 receptor agonists to reduce the risk of stroke in individuals with diabetes and high cardiovascular risk.

139

139

STAT

NOVEMBER 14, 2024

As a medical intern in the late 1980s, I’d occasionally see priests and rabbis on hospital wards, but we basically ignored one another. When we doctors walked into a patient’s room, they’d quickly leave, and when we exited, they’d enter. They seemed to operate in a wholly different realm. After all, we were scientific.

Hospitals 124

Hospitals 124

Fierce Pharma

NOVEMBER 14, 2024

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win.

122

122

Pharmacy Times

NOVEMBER 14, 2024

The intervention methods—annual asthma reviews, inhaler technique checks, and asthma management plans—were most effective when performed in the same visit.

132

132

Fierce Pharma

NOVEMBER 14, 2024

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | Upon reexamination, the EMA has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. But the recommendation for approval has a restriction.

119

119

Pharmacy Times

NOVEMBER 14, 2024

These therapies represent an encouraging advancement in cardiovascular care.

131

131

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

NOVEMBER 14, 2024

Centene President Ken Fasola will retire next summer, the insurer revealed | Ken Fasola joined the team at Centene in 2022 when the insurer completed its $2.2 billion acquisition of Magellan Health.

Insurance 118

Insurance 118

Pharmacy Times

NOVEMBER 14, 2024

Community pharmacists are playing an increasing role in sexual and reproductive health services and can provide that trustworthy information to patients.

127

127

STAT

NOVEMBER 14, 2024

The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing. The regulator criticized Merz for a few reasons concerning Xeomin, which is promoted as an alternative to Botox for combating wrinkle and frown lines.

FDA 118

FDA Pharmaceutical Companies Pharmaceutical Companies 118

Pharmacy Times

NOVEMBER 14, 2024

Increasing vaccine coverage among adults at highest risk could lessen associated hospitalizations and severe outcomes caused by RSV.

Hospitals 114

Hospitals Vaccines 114

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

NOVEMBER 14, 2024

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

112

112

STAT

NOVEMBER 14, 2024

Rise and shine, everyone, another busy day is on the way. We can tell by the sound of the motor vehicles passing by our window and the furious panting of the official mascots as they forage for breakfast on the campus grounds. Even Mrs. Pharmalot is up and about earlier than usual thanks to her own hectic agenda. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

102

102

pharmaphorum

NOVEMBER 14, 2024

GSK's multiple myeloma therapy Blenrep's increase in overall survival in the DREAMM-7 trial has achieved statistical significance

105

105

STAT

NOVEMBER 14, 2024

Why are AbbVie executives feeling the M&A blues? What does it take to slice $12 billion from Amgen’s market value? And why are STAT’s D.C. correspondents working so hard?  We talk about all that and more on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. It’s a “Chatty Cathy” episode!

110

110

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

NOVEMBER 14, 2024

The strongest association is found between asthma and the risk of attention deficit/hyperactivity disorder, though these links do not equate to causality.

102

102

STAT

NOVEMBER 14, 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it’s a good time to correct one of the more egregious misconceptions regarding the handling of patient subgroup data that has been floating persistently around the internet.

109

109

Pharmacy Times

NOVEMBER 14, 2024

Use of antitherapeutic medication prescribed for herpes zoster related to lower risk of subsequent dementia.

101

101

STAT

NOVEMBER 14, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning. I’m back on the newsletter beat today while Theresa’s on holiday, but I’m off to Chicago soon to cover the American Heart Association’s scientific sessions. Ping me if you’ll be following the conference, too.

99

99

Drug Topics

NOVEMBER 14, 2024

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.

98

98

Pharmaceutical Technology

NOVEMBER 14, 2024

The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene therapy in the US that is directly delivered to the brain.

FDA 98

FDA 98

Drug Topics

NOVEMBER 14, 2024

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

98

98

Pharmaceutical Technology

NOVEMBER 14, 2024

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

98

98

STAT

NOVEMBER 14, 2024

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company shuts down, and a deep dive on digital measures for tracking disease.

98

98

Pharmaceutical Technology

NOVEMBER 14, 2024

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a programmed death-ligand 1 and vascular endothelial growth factor A-targeting bispecific antibody.

98

98

pharmaphorum

NOVEMBER 14, 2024

Syncona launches Slingshot Therapeutics with a mission to find promising projects in academia and translate them into development projects.

98

98

Pharmaceutical Technology

NOVEMBER 14, 2024

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.

98

98

The Checkup by Singlecare

NOVEMBER 14, 2024

Injuries. Arthritis. Going bowling for the first time in ten years. Muscle soreness has a lot of causes, and almost as many solutions. But when you roll out of bed and your legs or back scream at you, your first thought might be to grab the ibuprofen. Non-steroidal anti-inflammatory drugs (NSAIDs) are a popular pain reliever for everyone from Olympic champions to people who slept in an awkward position—but does it truly work for sore muscles?

FDA 97

FDA 97

Outsourcing Pharma

NOVEMBER 14, 2024

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it unveils a $3.5 billion infusion into US sites.

93

93

The Checkup by Singlecare

NOVEMBER 14, 2024

For many people, Zyrtec is the main part of their arsenal against allergy symptoms like sneezing , runny nose , and itchy eyes. This brand-name over-the-counter ( OTC ) drug contains the active ingredient cetirizine , an antihistamine. Like everything else, too much of a good thing can turn into a bad thing. While many people find relief with Zyrtec when using it correctly, others might not be aware of the potential consequences of taking too much.

Dosage 85

Dosage Labelling Packaging 85